Abstract:Key Points Apoptosis, the cell-death programme that is mediated by proteases called caspases, is essential for tissue homeostasis, and its perturbed regulation underlies many diseases, including cancer. Commitment to apoptosis in response to diverse physiological cues and cytotoxic agents is governed by proteins of the Bcl2 family. Bcl2 and several pro-survival relatives associate with the mitochondrial outer membrane and the endoplasmic reticulum/nuclear membrane and maintain their integrity. Initiation of apoptosis requires not only pro-apoptotic family members such as Bax and Bak that closely resemble Bcl2, but also distant cousins that are related only by the small BH3 protein-interaction domain. The BH3-only proteins are sentinels that detect developmental death cues or intracellular damage. In healthy cells, they are restrained in diverse ways, including sequestration on the cytoskeleton. When unleashed by death signals, they switch off survival function by inserting their BH3 domain into a groove on their pro-survival relatives. Either Bax or Bak is required for apoptosis, but how they are activated or countermanded by Bcl2 remains uncertain. During apoptosis, Bax and Bak oligomerize in the mitochondrial outer membrane and probably breach its integrity, freeing pro-apoptotic proteins such as cytochrome c, which allows activation of caspase-9. The pro-survival Bcl2-like proteins can prevent cytochrome c release, and hence caspase-9 activation. They probably also regulate the activation of several other caspases, independently of mitochondrial damage. Impaired apoptosis is a central step towards neoplasia. Pro-survival Bcl2-like proteins can promote tumorigenesis, and certain pro-apoptotic relatives act as tumour suppressors. Moreover, the expression of family members is affected by other tumorigenic alterations (for example, p53 mutation). Conventional cytotoxic therapy indirectly induces apoptosis, but more effective outcomes should be achieved by direct activation of the apoptotic machinery. Promising approaches include impairing expression of pro-survival Bcl2-like proteins or identifying drugs that mimic the action of BH3-only proteins.

Bim and Bmf in tissue homeostasis and malignant disease

BNIP3 Heterodimerizes with Bcl-2/Bcl-XL and Induces Cell Death Independent of a Bcl-2 Homology 3 (BH3) Domain at Both Mitochondrial and Nonmitochondrial Sites

The BCL-2 protein family: opposing activities that mediate cell death

The Major Isoforms of Bim Contribute to Distinct Biological Activities That Govern the Processes of Autophagy and Apoptosis in Interleukin-7 Dependent Lymphocytes.

Loss of BIM increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice

Macrophage Migration Inhibitory Factor (mif) Interacts with Bim and Inhibits Bim-Mediated Apoptosis

Research Progress on BMF Proapoptosis

Canonical and Noncanonical Functions of the BH3 Domain Protein Bid in Apoptosis, Oncogenesis, Cancer Therapeutics, and Aging

Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice

The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms

BAX inhibitor‐1: between stress and survival

The Bcl2 family: regulators of the cellular life-or-death switch

Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim.

Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

Bim is Required for T-cell Allogeneic Responses and Graft-Versus-host Disease in Vivo.

Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatment

Metazoans and Intrinsic Apoptosis: An Evolutionary Analysis of the Bcl-2 Family

Overexpression of BimSs3, the Novel Isoform of Bim, Can Trigger Cell Apoptosis by Inducing Cytochrome C Release from Mitochondria.

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

The BH3 Α-Helical Mimic BH3-M6 Disrupts Bcl-XL, Bcl-2, and MCL-1 Protein-Protein Interactions with Bax, Bak, Bad, or Bim and Induces Apoptosis in a Bax- and Bim-dependent Manner

BCL-2 inhibition in haematological malignancies: Clinical application and complications